Αρχική World News Italian Association of Oncology Nurses Maps the Situation of Cancer Patients Who...

Italian Association of Oncology Nurses Maps the Situation of Cancer Patients Who are Self-Isolated at Home

In a letter to the editor published in the August 2020 issue of the European Journal of Cancer, a group of oncology nurses communicated an interim analysis of survey data collected between 29 March and 3 May 2020 by the Italian Association of Oncology Nurses, as an effort to map the situation of the self-isolated patients with cancer at home in the context of the COVID-19 pandemic.

They reported data from 195 patients who completed the survey. The respondents were mainly women (75.9%), with a mean age of 50.3 years (range 25-78) and a high level of education (66,34%). The majority of patients had haematological malignancies (51.3%), followed by patients with breast cancer (26.2%) and other solid tumours (22.6%). The majority of patients were from the north of Italy (38.9%), followed by those from the south (34.7%) and from central Italian regions (26.4%).

Findings of investigated survey topics indicate that 21.1% of study participants did not leave the home at all during the study period, while 59.3% only rarely. The reasons for leaving the home were mainly related to health or going to supermarket, while in only 8.3% for job reasons.

In terms of changes in relations with family members, 31.9% reported no kisses and hugs, 12% practising social distance, 6.8% using separate rooms and other measures were reported in 6.8% of cases. 

The Italian oncology nurses commented that the patients with cancer not only were considered at higher risk for COVID-19 infection, but they also had to suffer from reduced cancer care activities. Almost one third of patients (29%) reported that their cancer was not under control. Many patients experienced difficult access to safe cancer care (62%), especially regarding follow-up visits, which were often postponed.

Furthermore, patients with cancer were afraid to go to the hospital even when they needed and even decided to cancel their appointments. Increased perception of hospitals as places where people get infected could have added further uncertainty to patients whose illness anxiety has already been negatively influencing their mental wellbeing. Moreover, 44% of study participants reported the fear that their cancer diagnosis would be regarded as of secondary importance in time of COVID-19 pandemic. Therefore, the oncology nurses highlighted that health professionals should help patients in prioritising their own health needs.

Patients with cancer usually feel more vulnerable than the general population and are more used to hypervigilance and protective measures, so it is not surprising that they adopted COVID-19 preventive behaviours promptly. However, only 54% believed to be at higher risk for COVID-19 infection and 51% for complications.

In order to reduce the likelihood of being infected, about one third of study participants reported taking supplements which are not recommended by health professionals due to the lack of evidence from ongoing clinical trials. On the other hand, self-care strategies such as a well balanced diet, regular exercise and good relationships seem to be underestimated for their potential to support the immune response.

The oncology nurses underlined that ensuring continuum of care is the key to success in COVID-19 and cancer management, as well as the strong need of keeping the connection between health needs and cancer management.

Reference

Biagioli V, Belloni S, Albanesi B, et al. Comment on “The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region” and reflections from the Italian Association of Oncology Nurses. European Journal of Cancer 2020; 135:8-10.

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Breast Cancer Survivor Invents Warming Bra Insert to Combat Cold Feeling of Breast Implants

In 2013, Kristen Carbone, of Providence, Rhode Island, had a preventative mastectomy to help protect herself against breast cancer after her mother died of...

FDA Approves Daratumumab plus Hyaluronidase-fihj, Carfilzomib, and Dexamethasone for Relapsed or Refractory Multiple Myeloma

On 30 November 2021, the US Food and Drug Administration (FDA) approved daratumumab plus hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) and carfilzomib (Kyprolis, Amgen,...

Thanks For Making This GivingTuesday Our Best One Yet!

We set ambitious goals for GivingTuesday, but they were driven by a time of great need. With your help, we hoped to provide food and...

Over 600 people in England set to benefit from innovative lung cancer treatment

<img width="620" height="348" src="https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero.jpg" class="attachment-featuredImage size-featuredImage" alt="Lung cancer cell" loading="lazy" srcset="https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero.jpg 620w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-300x168.jpg 300w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-220x123.jpg 220w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-150x84.jpg 150w" sizes="(max-width: 620px) 100vw, 620px" data-attachment-id="18781" data-permalink="https://news.cancerresearchuk.org/2020/09/11/targeted-drug-for-lung-cancer-approved-for-nhs-use-in-england/lung_cell_cropped-hero/"...

Touching a nerve: How neuroscience could advance our understanding of cancer

KTSDESIGN/SCIENCE PHOTO LIBRARY When supporters donate to our work, their combined generosity might lead to a new discovery that inches us closer to, for example,...

Nivolumab Demonstrates Clinical Benefits in a Statistically Evaluable Number of Patients with CUP

An investigator-initiated phase II study is the first to show that nivolumab has clinical activity with manageable toxicity in a statistically evaluable number of...